Nexpoint Real Estate Finance Stock Earnings Reports

NexPoint Real Estate Finance reported Q1 2026 results with net income of $0.42 per diluted share (down from $0.70 year-over-year) driven by small MTM losses, while Earnings Available for Distribution (EAD) was $0.43 and Cash Available for Distribution (CAD) was $0.58 per diluted share. The company paid and declared a $0.50 quarterly dividend. Key balance sheet moves include refinancing $180M of maturing 5.75% unsecured notes with a $242M total return swap (TRS) facility at SOFR + 375 bps (3-year term with one-year extension), which (per management) removes a near-term liability overhang, better aligns funding with floating-rate assets, provides ~$45M incremental deployment capacity, and permits back-lever optionality. They executed a re-REMIC sale of FRAN 2017-K62 B-Piece to Mizuho (sold at 92.7 after buying at 68.69), reinvesting into an HRR tranche at an 18.5% yield; this transaction reportedly produced $0.46 per share of book value appreciation, reduced repo financing by $75M, and is expected to drive ~$0.34 per share of annual CAD accretion. Portfolio: ~90 investments, $1.1B outstanding; sector mix ~56% residential (multifamily + SFR), ~36% life sciences, remainder storage, industrial, marina; 81.2% of collateral stabilized, WA LTV ~59.9%, WA DSCR 1.32x. Debt outstanding $665.2M, WA cost 5.2%, WA maturity 0.8 years; net debt-to-equity below 1x. Pipeline: ~$190M across 11 active deals plus ~$275M of structured product opportunities; management sees attractive spreads and expects TRS benefits to increase CAD. Management highlights secular tailwinds for multifamily (supply trough), improving life-science demand (AI widening tenant funnel), outperformance in self-storage portfolio, and a company-wide AI initiative to accelerate underwriting, monitoring, and reporting. They plan opportunistic buybacks given shares trade at a meaningful discount to book (~$19) while continuing pipeline deployment. Q2 guidance: EAD $0.38–$0.48 (midpoint $0.43) and CAD $0.49–$0.59 (midpoint $0.54).